Certara (CERT) vs Definitive Healthcare (DH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Certara (CERT) has outperformed Definitive Healthcare (DH) over the past year, losing 33.5% versus a loss of 70.1%. Over five years, CERT leads with a -77.2% price change compared with -97.7% for DH. Certara is the larger company by market cap ($1.32 billion vs $103.1 million), about 12.8 times the size.
On valuation, Definitive Healthcare trades at a lower forward P/E (5.2x vs 22.2x for Certara).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | DH |
|---|---|---|
| Share price | $8.64 | $0.9663 |
| Market cap | $1.32B | $103.15M |
| 1-day change | -3.57% | -0.41% |
| YTD return | -1.93% | -66.33% |
| 1-year return | -33.54% | -70.08% |
| 5-year return | -77.17% | -97.72% |
| Forward P/E | 22.17 | 5.18 |
| EPS (TTM) | $-0.13 | $-1.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.11 | $3.15 |
| 52-week low | $4.45 | $0.61 |
| Distance from 52-week high | -34.10% | -69.31% |
| Analyst consensus | buy | none |
| Avg. price target upside | +0.81% | +96.63% |
| Average volume | 3.10M | 586.27K |
| Shares outstanding | 152.54M | 106.74M |
| Employees | 1,515 | 678 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Certara is about 12.8 times larger than Definitive Healthcare by market value ($1.32B vs $103.15M).
- CERT has outperformed DH by 36.5 percentage points over the past year.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Healthcare · Health Information Services · 1,515 employees
About Definitive Healthcare
DH stock →Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Healthcare · Health Information Services · 678 employees
CERT vs DH FAQ
Which is bigger, Certara or Definitive Healthcare?
Certara (CERT) is larger, with a market capitalization of $1.32B compared with $103.15M for Definitive Healthcare (DH).
Which stock has performed better over the past year, CERT or DH?
CERT returned -33.54% over the past 12 months, compared with -70.08% for DH (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Definitive Healthcare in the same industry?
Yes. Both are classified in the Health Information Services industry within the Healthcare sector.